Renal Cell Carcinoma (RCC) research hub
3 indexed studies · 2 currently recruiting
- recruitingPHASE1
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
This study is testing a new drug, zanzalintinib, alone and with other medicines, for people with advanced cancers like kidney, prostate, and lung cancer. It's looking at safety and if the treatment shrinks tumours.
United States · Australia · Austria - not yet recruiting
Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
This study looks at how new imaging technology helps treat cancers in the liver, lung, and bone. It collects information from patients already receiving these treatments to see if the advanced scans can improve planning and results in the future.
France · Netherlands - ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase III, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Atezolizumab Given in Combination with Cabozantinib Versus Cabozantinib Alone in Patients With Inoperable, Locally Advanced, or Metastatic Renal Cell Carcinoma Who Experienced Radiographic Tumor Progression During or After Immune Checkpoint Inhibitor Treatment
This study looks at a new combination treatment for advanced kidney cancer that has grown despite earlier immune-boosting treatment. Researchers want to see if combining two drugs, Atezolizumab and Cabozantinib, works better than Cabozantinib alone to control the cancer and help people live longer.
Poland · Germany